MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
As of today, MacroGenics(MGNX) shares are valued at $2.93. The company's market cap stands at 186.29M, with a P/E ratio of -2.60.
As of 2026-03-18, MacroGenics(MGNX) stock has fluctuated between $2.92 and $3.12. The current price stands at $2.93, placing the stock +0.4% above today's low and -5.9% off the high.
MacroGenics(MGNX) shares are trading with a volume of 537.09K, against a daily average of 2.62M.
During the past year, MacroGenics(MGNX) stock moved between $0.99 at its lowest and $3.54 at its peak.
During the past year, MacroGenics(MGNX) stock moved between $0.99 at its lowest and $3.54 at its peak.
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.